Population
9669 healthy blood donors
Design
Cohort
Authors
Loading...
Higher prevalence of congenital AT deficiency (1 in 600) in donors than prior estimates; leaves open its thrombotic risk implications and screening utility.
Congenital antithrombin deficiency is present in approximately 1 in 600 healthy blood donors, with type II deficiency being more common and relatively asymptomatic.
Tait et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: